Is Rituximab-induced Late-onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders?

被引：13
作者：
Hincks, Ian [1 ]
Woodcock, Barrie E. [1 ]
Thachil, Jecko [2 ]
机构：
[1] Aintree Univ Hosp NHS Fdn Trust, Dept Haematol, Liverpool L9 7AL, Merseyside, England
[2] Royal Liverpool Univ Hosp, Dept Haematol, Liverpool, Merseyside, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 153卷 / 03期
关键词：
lymphoma; neutropenia; rituximab; STEM-CELL TRANSPLANTATION; LYMPHOMA; CHEMOTHERAPY; THERAPY; SERIES;
D O I：
10.1111/j.1365-2141.2010.08563.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：411 / 413
页数：3
相关论文
共 10 条
  • [1] Cairoli R, 2004, HAEMATOLOGICA, V89, P361
  • [2] Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments
    Cattaneo, Chiara
    Spedini, Pierangelo
    Casari, Salvatore
    Re, Alessandro
    Tucci, Alessandra
    Borlenghi, Erika
    Ungari, Marco
    Ruggeri, Giulia
    Rossi, Giuseppe
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 1013 - 1017
  • [3] Delayed-onset neutropenia associated with rituximab therapy
    Chaiwatanatorn, K
    Lee, N
    Grigg, A
    Filshie, R
    Firkin, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (06) : 913 - 918
  • [4] B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis
    Dunleavy, K
    Hakim, F
    Kim, HK
    Janik, JE
    Grant, N
    Nakayama, T
    White, T
    Wright, G
    Kwak, L
    Gress, R
    Tosato, G
    Wilson, WH
    [J]. BLOOD, 2005, 106 (03) : 795 - 802
  • [5] Late Onset Neutropenia and Immunoglobulin Suppression of the Patients with Malignant Lymphoma Following Autologous Stem Cell Transplantation with Rituximab
    Hirayama, Yasuo
    Kohda, Kyuhei
    Konuma, Yuichi
    Hirata, Yasuji
    Kuroda, Hiroyuki
    Fujimi, Yuko
    Shirao, Sayaka
    Kobune, Masayoshi
    Takimoto, Rishu
    Matsunaga, Takuya
    Kato, Junji
    [J]. INTERNAL MEDICINE, 2009, 48 (01) : 57 - 60
  • [6] Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma
    Lai, Gillianne Geet Yi
    Lim, Soon-Thye
    Tao, Miriam
    Chan, Alexandre
    Li, Huihua
    Quek, Richard
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 414 - 417
  • [7] Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
    Lemieux, B
    Tartas, S
    Traulle, C
    Espinouse, D
    Thieblemont, C
    Bouafia, F
    Alhusein, Q
    Antal, D
    Salles, G
    Coiffier, B
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 921 - 923
  • [8] A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
    Nitta, E.
    Izutsu, K.
    Sato, T.
    Ota, Y.
    Takeuchi, K.
    Kamijo, A.
    Takahashi, K.
    Oshima, K.
    Kanda, Y.
    Chiba, S.
    Motokura, T.
    Kurokawa, M.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (02) : 364 - 369
  • [9] Voog E, 2003, NEW ENGL J MED, V348, P2691
  • [10] Late-Onset Neutropenia After Rituximab Treatment Case Series and Comprehensive Review of the Literature
    Wolach, Ofir
    Bairey, Osnat
    Lahav, Meir
    [J]. MEDICINE, 2010, 89 (05) : 308 - 318
1